![Jean-Pierre Garnier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jean-Pierre Garnier
Président chez
CELLECTIS S.A.
Fortune : 1 M $ au 31/01/2026
Profil
Jean-Pierre Garnier est un homme d'affaires français qui a été à la tête de 14 entreprises différentes et occupe actuellement le poste de président non exécutif de Cellectis SA et de président de Carmat SA. Le Dr Garnier est également membre du conseil d'administration de Radius Health, Inc. et de l'Institut Max Planck de chimie biophysique, de Carrier Global Corp. et partenaire opérationnel d'Advent International LLC. Il a précédemment occupé le poste de président de NormOxys, Inc. et d'Alzheon, Inc. ainsi que celui de président d'ABIONYX Pharma SA et de Cerenis Therapeutics, Inc. (une filiale d'ABIONYX Pharma SA), président d'Idorsia Ltd, président d'Idorsia Pharmaceuticals Ltd, directeur général de GlaxoSmithKline Plc et directeur général de Smithkline Beecham Plc (une filiale de GlaxoSmithKline Plc), président de e.Nvizion Communications Group Ltd, directeur d'Actelion Ltd, directeur général de Pierre Fabre SA, président de Schering-Plough Corp. et conseiller de Quaker Partners Management LP. Le Dr Garnier a obtenu un MBA de l'Université de Stanford et un doctorat et un diplôme d'études supérieures de l'Université Louis Pasteur.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 09/04/2025 | 18 110 ( 0 % ) | 1 M $ | 31/01/2026 | |
CELLECTIS S.A. -.--% | 15/02/2025 | 0 ( -.--% ) | - $ | 31/01/2026 |
BIOAGE LABS, INC. -.--% | 05/06/2025 | 0 ( -.--% ) | - $ | 31/01/2026 |
Dernières actualités sur Jean-Pierre Garnier
Postes actifs de Jean-Pierre Garnier
| Sociétés | Poste | Début |
|---|---|---|
| CARRIER GLOBAL CORPORATION | Directeur/Membre du Conseil | 03/04/2020 |
| CELLECTIS S.A. | Président | 05/11/2020 |
| BIOAGE LABS, INC. | Président | 20/08/2024 |
Carrier Corp.
 Carrier Corp. Industrial MachineryProducer Manufacturing Manufactures air conditioning, heating & refrigeration equipment | Directeur/Membre du Conseil | - |
Advent International LLC
 Advent International LLC Investment ManagersFinance Provides risk capital and investments | Corporate Officer/Principal | - |
Anciens postes connus de Jean-Pierre Garnier
| Sociétés | Poste | Fin |
|---|---|---|
| CARMAT | Président | 22/12/2022 |
| RADIUS HEALTH, INC. | Directeur/Membre du Conseil | 15/08/2022 |
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Develops and commercializes pharmaceuticals | Président | 13/05/2020 |
| IDORSIA LTD | Président | 13/05/2020 |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jean-Pierre Garnier
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Schering-Plough Corp.
 Schering-Plough Corp. Manufactures and sells pharmaceutical & health care products | |
United Technologies Corp.
 United Technologies Corp. Manufactures engine parts, elevators, and air-conditioning equipment | |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
e.Nvizion Communications Group Ltd.
 e.Nvizion Communications Group Ltd. Financial ConglomeratesFinance Development stage company | Finance |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Advent International LLC
Advent International LLC Investment ManagersFinance Provides risk capital and investments | Finance |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule therapeutics for the treatment of cancer | Health Technology |
Newman's Own Foundation
 Newman's Own Foundation Operates as a charity | |
Alzheon, Inc.
 Alzheon, Inc. Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renault SA
 Renault SA Motor VehiclesConsumer Durables Manufactures and distributes automobiles and other motor vehicles | Consumer Durables |
Carrier Corp.
Carrier Corp. Industrial MachineryProducer Manufacturing Manufactures air conditioning, heating & refrigeration equipment | Producer Manufacturing |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces and markets pharmaceutical drugs | Health Technology |
Pierre Fabre SA
 Pierre Fabre SA BiotechnologyHealth Technology Engages in research and preclinical development of biologics & pharmaceuticals | Health Technology |
Pierre Fabre Participations SAS
 Pierre Fabre Participations SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes dermatology and cosmetic products | Health Technology |
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Finance |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs | Health Technology |
Carmat SA
 Carmat SA Medical SpecialtiesHealth Technology Specializes in the construction of artificial hearts | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Max Planck Institute For Biophysical Chemistry
 Max Planck Institute For Biophysical Chemistry Functions as a College/University | |
Max Planck Florida Institute for Neuroscience
 Max Planck Florida Institute for Neuroscience Researches and develops on neuroscience | |
BioAge Labs, Inc.
 BioAge Labs, Inc. Develops therapies obesity for metabolic diseases | |
Idorsia Ltd.
 Idorsia Ltd. Engages in the discovery, development and commercialization of medicines for unmet medical needs | |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Develops and commercializes pharmaceuticals | |
Carrier Global Corp.
 Carrier Global Corp. Manufactures, sells and installs HVAC, refrigeration, fire and security solutions | |
Louis Pasteur University
 Louis Pasteur University Functions as a College/University |
